$INO Hmmmm...why INO headed higher and why it will be heading higher. "Dr. Kim stated that INO-4800's planned phase 2/3 trial should get clearance from the Food and Drug Administration soon. He also noted that he felt "very confident" this pivotal trial would receive external funding -- perhaps foreshadowing a large award from Operation Warp Speed in the near future. There's a decent chance that the biotech could indeed land a sizable award for its COVID-19 vaccine. So, if you're the risk-tolerant type, it might be worthwhile to buy a few shares ahead of this potential catalyst. " fool.com/investing/2020/09/...
  • 5
5 Likes